Skip to main content
Veterinary Medicines

FELIGEN CRP

Authorised
  • Feline panleucopenia virus, strain LR 72, Live
  • Feline rhinotracheitis virus, strain F2, Live
  • Feline calicivirus, strain F9, Live

Product identification

Medicine name:
FELIGEN CRP
Active substance:
  • Feline panleucopenia virus, strain LR 72, Live
  • Feline rhinotracheitis virus, strain F2, Live
  • Feline calicivirus, strain F9, Live
Target species:
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Feline panleucopenia virus, strain LR 72, Live
    4.50
    cell culture infective dose 50
    /
    1.00
    millilitre(s)
  • Feline rhinotracheitis virus, strain F2, Live
    6.60
    cell culture infective dose 50
    /
    1.00
    millilitre(s)
  • Feline calicivirus, strain F9, Live
    6.10
    cell culture infective dose 50
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AD04
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Virbac Espana S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • (AEMPS)
Authorisation number:
  • 3265 ESP
Date of authorisation status change:

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."